Physician profile
Foad Elahi
NPI 1154657716
$61,621.20
in general payments reported to CMS, 2019-2025
14 companies · $5,877 in 2025
The $5,877 reported for 2025 was more than what 95% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $5,309 · 2021: $9,518 · 2022: $8,973 · 2023: $1,639 · 2024: $3,101 · 2025: $5,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,221 · Consulting Fee: $3,563 · Travel and Lodging: $1,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,221.17 |
| Consulting Fee | $3,562.50 |
| Travel and Lodging | $1,833.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $51,999.33 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Click |
| Bioness INC | $4,928.56 | 2019 | |
| Bioventus LLC | $1,551.39 | 2025 | Stimrouter Implantable Kit |
| Curonix LLC | $699.76 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $555.61 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Medtronic USA, INC. | $423.75 | 2019-2020 | |
| Stryker Corporation | $341.91 | 2020-2023 | Spinejack |
| Flowonix Medical Incorporated | $247.57 | 2020 | |
| Zynex Medical, INC. | $234.88 | 2025 | Nexwave |
| Painteq LLC | $190.14 | 2021-2024 | Painteq |
| Nevro Corp. | $175.74 | 2019-2020 | |
| Abbott Laboratories | $129.79 | 2022-2024 | Proclaim |
| Medtronic, INC. | $119.12 | 2021-2025 | Synchromedii, Inceptiv |
| Si-Bone, INC. | $23.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Foad Elahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.